StockData
CVS HEALTH Corp logo

CVS HEALTH Corp

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$88.51−1.74 (-1.93%)

Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%

Cvs Health Claims Paid — Current Year Incurred by Quarter

Claims Paid — Current Year Incurred ($M)

QuarterlyAnnual

Cvs Health Claims Paid — Current Year Incurred: $29,752M in Q2 2026, up 0.9% from a year earlier.

Latest, Q2 2026
29,752
Period ended Jun 30, 2026
Change on a year earlier
+0.9%
29,479 in Q2 2025
History
13 quarters
Since Q1 2019
Sources
2
Documents cited below

Where the Q2 2026 figure comes from

Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)

Source: CVS SEC 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedClaims Paid — Current Year Incurred ($M)Year on yearSource
Q2 2026Jun 30, 202629,752+0.9%CVS SEC 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1) ↗
Q1 2026Mar 31, 202618,255-5.5%CVS SEC 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1) ↗
Q4 2025Dec 31, 202533,336+10.3%CVS SEC 10-K (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1) ↗
Q3 2025Sep 30, 202530,896+9.8%CVS SEC 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1) ↗
Q2 2025Jun 30, 202529,479+9.4%CVS SEC 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1) ↗
Q1 2025Mar 31, 202519,312+18.7%CVS SEC 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1) ↗
Q4 2024Dec 31, 202430,227+33.9%CVS SEC 10-K (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1) ↗
Q3 2024Sep 30, 202428,138+37.6%CVS SEC 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1) ↗
Q2 2024Jun 30, 202426,955–CVS SEC 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1) ↗
Q1 2024Mar 31, 202416,263–CVS SEC 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1) ↗
Q4 2023Dec 31, 202322,577–CVS SEC 10-K (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1) ↗
Q3 2023Sep 30, 202320,450–CVS SEC 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1) ↗
Q1 2019Mar 31, 20198,004–CVS SEC 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1) ↗

Cite this data

StockData. (2026). Cvs Health Claims Paid — Current Year Incurred ($M), quarterly Q1 2019–Q2 2026 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/med-paid-current-yr

See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.